Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Sarcoma

Paradise Awaits, One Day At a Time

Steve Rubin

I'm keeping hope alive that eventually, we'll get through the other side of the COVID-19 pandemic. One day at a time like anything else.

'Yet' Makes All the Difference

Steve Rubin

It's pretty clear that I have a lot of work ahead of me after years of devastation from cancer, but lately, I'm taking a new approach.

What You Need to Know About the FDA's Approval of Tazverik For Epithelioid Sarcoma

Conor Killmurray

Patients with epithelioid sarcoma finally have a specific treatment after the FDA granted accelerated approval to Tazverik, providing new hope for the future of these patients.

FDA Approves Tazverik For Epithelioid Sarcoma

Conor Killmurray

The Food and Drug Administration approved Tazverik for the treatment of patients with metastatic or locally advanced epithelioid sarcoma — marking the first treatment option specifically for these patients.

With a Little Help from My Friends

Steve Rubin

Having loved ones by your side is right up there in importance with any aspect of healing from cancer.

All the Answers

Steve Rubin

Thoughts on New Year's resolutions and planning for the years ahead when your future is tied up in uncertainty because of cancer.

Friday Frontline: Cancer Updates, Research and Education on December 20, 2019

Katie Kosko

From a newly proposed rule to help lower prescription drug prices to an oncology nurse and a patient with cancer singing “O Holy Night,” here’s what is making headlines in the cancer space this week.

Triumph Over Cancer: Riding 'Coast 2 Coast'

Kristie L. Kahl

Now a 10-year survivor of bone cancer, Dana Vaughns chose to triumph over his disease and joined Bristol-Myers Squibb on its Coast 2 Coast 4 Cancer ride.

Ten-Year Bone Cancer Survivor Rides 'Coast 2 Coast'

Kristie L. Kahl

Dana Vaughns and his colleagues rode 3,000 miles across the U.S. in support of funding research for the V Foundation.

Studying Rare Diseases Is Difficult, But Innovation Drives Results

Debu Tripathy, M.D.

Where does hope lie when it comes to improving the treatment landscape for rare cancers?

Sarcoma

Sign In